Don DeGolyer

Senior Advisor and Board Member

Don DeGolyer is a prominent figure in the healthcare sector, currently serving as a Board Director at Emergent BioSolutions since October 2023. He brings over 35 years of experience in pharmaceuticals, health technology, and corporate leadership. His career has included significant roles in various companies, where he has demonstrated expertise in market development, strategic vision, and team building.1 2 3

Professional Background

Current Role: Board Director at Emergent BioSolutions
- Joined the board in October 2023.
- Also serves on the Compensation Committee and the Special Transactions Committee.3 4
Previous Positions:
- Founder and CEO of Vertice Pharma, where he led the company for nearly seven years.
- Chief Operating Officer at Endo International plc.
- CEO of Sandoz Inc., a subsidiary of Novartis.
- Held various senior roles at Novartis, including SVP for Managed Care & Established Products.1 2

Areas of Expertise

Don DeGolyer's expertise spans several critical areas within the healthcare industry:

Pharmaceutical Development: Experience in branded products, generic pharmaceuticals, and specialty drugs.
Market Strategy: Proven track record in creating commercial strategies for product launches and market access.
Leadership: Known for building high-performance teams and aligning organizational goals with market needs.1 2

Community Involvement

In addition to his corporate roles, DeGolyer is actively involved in community service:

He serves on the board of directors for Make-A-Wish New Jersey.
He founded the Strong Women Foundation, which aims to support single mothers and their children through financial, educational, and health initiatives.1

DeGolyer's extensive background and leadership experience position him as a valuable asset to Emergent BioSolutions and the broader healthcare community.